Riskpilot← Back to searchSign inGet full accessBELDO HELSE AS
ASActiveOrg 994950754Reistadhaugen 7, 9513 AltaOther human health activities n.e.c. · NACE 8699Est. 20103 employees
Revenue 2025
NOK 2,6M
-6% vs 2024
EBITDA margin
-2.4%
-163% vs 2024
Equity ratio
80.9%
Financial strength
Net profit 2025
NOK -38K
-108% vs 2024
| Revenue | NOK 2,6M | -6% |
| EBITDA | NOK -63K | -163% |
| Net profit | NOK -38K | -108% |
| Total assets | NOK 2,1M | -3% |
| Equity | NOK 1,7M | -2% |
| Employees | 3 | — |
Legal name
BELDO HELSE AS
Org number
994950754
Legal form
Aksjeselskap
NACE code
8699 · Other human health activities n.e.c.
Founded
7. januar 2010
Share capital
NOK 300 000
Employees
3 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Drive helsetjenester og frisktrening rettet både mot privatpersoner og bedrifter, samt beslektet virksomheter.
Address
Reistadhaugen 7, 9513 Alta
Phone
+4799016989
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1 903 | 1 875 | 1 935 | 2 426 | 2 379 | 2 560 | 2 337 | 2 352 | 2 466 | 2 321 | 2 091 | 3 379 | 2 567 | 2 706 | 2 780 | 2 615 |
| Staff expenses | −1 012 | −1 090 | −1 108 | −1 178 | −1 181 | −1 313 | −1 458 | −1 491 | −1 881 | −1 545 | −1 704 | −1 872 | −1 643 | −1 888 | −1 701 | −1 737 |
| EBITDA | 297 | 103 | 167 | 568 | 658 | 634 | 289 | 328 | 95 | 293 | −39 | 1 012 | 251 | 1 | −24 | −63 |
| Depreciation & amort. | −8 | −11 | −11 | −225 | −258 | −266 | −277 | −307 | −176 | −147 | −209 | −87 | −38 | −8 | −8 | −8 |
| EBIT | 288 | 92 | 156 | 343 | 400 | 368 | 12 | 21 | −81 | 146 | −248 | 925 | 214 | −6 | −32 | −71 |
| Net financials | 0 | 2 | 3 | −124 | −110 | −86 | −83 | −75 | −64 | −60 | −47 | −24 | −0 | −1 | 8 | 22 |
| Profit before tax | 289 | 93 | 160 | 219 | 290 | 282 | −70 | −54 | −145 | 86 | −296 | 901 | 213 | −7 | −23 | −49 |
| Tax | 78 | 28 | 47 | 57 | 78 | 77 | −16 | −10 | −29 | 22 | −65 | 198 | 47 | −1 | −5 | −11 |
| Net profit | 211 | 65 | 113 | 162 | 212 | 204 | −54 | −44 | −116 | 64 | −231 | 703 | 167 | −6 | −18 | −38 |
| Item | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 526 | 559 | 687 | 3 510 | 3 578 | 3 648 | 3 368 | 3 185 | 2 888 | 2 767 | 2 491 | 2 014 | 2 222 | 2 200 | 2 157 | 2 094 |
| Equity | 311 | 376 | 489 | 851 | 1 062 | 1 267 | 1 212 | 1 169 | 1 053 | 1 117 | 886 | 1 589 | 1 756 | 1 750 | 1 732 | 1 693 |
| Long-term debt | 0 | 0 | 0 | 2 377 | 2 211 | 2 042 | 1 875 | 1 708 | 1 542 | 1 375 | 1 208 | 71 | 68 | 55 | 39 | 0 |
| Short-term debt | 216 | 184 | 199 | 282 | 304 | 340 | 281 | 308 | 294 | 275 | 397 | 353 | 398 | 395 | 386 | 372 |
| Total debt | 216 | 184 | 199 | 2 659 | 2 516 | 2 382 | 2 156 | 2 016 | 1 836 | 1 650 | 1 605 | 425 | 466 | 450 | 426 | 401 |
EBITDA margin
-2.4%
This company
15.8%
Market median
-115% vs market
20102025
Equity ratio
80.9%
This company
38.2%
Market median
+112% vs market
20102025
Return on equity
-2.3%
This company
18.4%
Market median
-113% vs market
20102025
Net profit margin
-1.5%
This company
8.1%
Market median
-119% vs market
20102025
Asset turnover
1.25×
This company
1.12×
Market median
+12% vs market
20102025
Debt / equity
0.24×
This company
0.62×
Market median
+61% vs market
20102025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via Brønnøysundsregistrene · Period 2012-01-01 – 2012-12-31
- Annual report 2011Filed via Brønnøysundsregistrene · Period 2011-01-01 – 2011-12-31
- Annual report 2010Filed via Brønnøysundsregistrene · Period 2010-01-01 – 2010-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
AH Deputy Member | Deputy Member | 2010 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2010 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 50.0% | 50.0% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
BELDO HELSE AS 
KLINIKK ELVEBAKKEN ASBoard members of BELDO HELSE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anna Helen Margret Jonsson | Deputy Member | 0 companies |
| Odd Georg Beldo | Chairman | 0 companies |